- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01107366
ATLANTIS:Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal Aneurysms Repair With LupiAe Hybrid TechNique (ATLANTIS)
Extensive Type A Dissections and Thoracic/ Thoraco-Abdominal
To prospectively evaluate the safety and efficacy of the LUPIAE hybrid technique for the treatment of
- thoracic or thoraco-abdominal aortic aneurysms
- thoracic aortic type A dissections 2. to compare the safety and efficacy of the LUPIAE hybrid technique with historical groups (literature review, other hybrid techniques, LUPIAE retrospective patients)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
LUPIAE technique:
Hybrid repair of thoracic or thoraco-abdominal aneurysms of different etiology and type A dissections with a two-stage procedure:
- surgical arch reconstruction with a Dacron multibranched surgical prothesis
- endovascular implantation of a thoracic stent graft
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
-
Bologna, Italy, 40138
- Policlinico S Orsola Malpighi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Patient willing to sign the informed consent, or In case of acute patients that should arrive at the hospital in unconsciousness status, patient's first degree relatives willingness to sign the informed consent and patient's willingness to re-consent for the study participation once he/she is again conscious.
and
Patients with extensive thoracic or thoraco-abdominal aortic aneurysms (>55 mm diameter), involving the ascending, arch and descending aortic segments, but not involving the renal arteries (at least 15 mm of healthy tissue above the most proximal renal artery).
Or
Patients with extensive type A aortic dissection (DeBakey type I) with at least one of the following minimum criteria:
- An initial false lumen diameter measured in the upper descending thoracic aorta >22 mm;
- Total aortic diameter measured in the descending thoracic aorta >45 mm;
- True lumen's compression (True lumen <10% of total aortic lumen);
- Non-controlled hypertension;
- Persistent pain;
- Rupture or imminent rupture;
Exclusion Criteria:
- Patient has a standard contraindication to the implant of thoracic stent graft;
- Patient unable to commit to follow-up schedule;
- Patient has medical conditions that preclude protocol required testing or limit study participation;
- Patient is enrolled or intend to participate in another clinical trial during the course of this study;
- Less than 18 years of age;
- Pregnancy;
- A life expectancy of less than one year, except for Patients with extensive type A aortic dissection (DeBakey type I)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: SINGLE_GROUP
- Masking: NONE
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
all cause mortality
Time Frame: 12 months
|
12 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ATLANTIS BOLOGNA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.